- 全部删除
- 您的购物车当前为空
Sotuletinib hydrochloride (BLZ945 HCl)是一种选择性和脑渗透性的CSF-1R(c-Fms)抑制剂 (IC50=1 nM),选择性是其他受体酪氨酸激酶同系物的1000倍,能提高肝酶并导致Kupffer细胞耗竭,可用于研究肌萎缩侧索硬化症(ALS)和转移性三阴性乳腺癌(TNBC)。
Sotuletinib hydrochloride (BLZ945 HCl)是一种选择性和脑渗透性的CSF-1R(c-Fms)抑制剂 (IC50=1 nM),选择性是其他受体酪氨酸激酶同系物的1000倍,能提高肝酶并导致Kupffer细胞耗竭,可用于研究肌萎缩侧索硬化症(ALS)和转移性三阴性乳腺癌(TNBC)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 315 | In stock | |
5 mg | ¥ 745 | In stock | |
10 mg | ¥ 1,160 | In stock | |
25 mg | ¥ 2,170 | In stock | |
50 mg | ¥ 2,320 | In stock | |
100 mg | ¥ 3,980 | In stock | |
200 mg | ¥ 5,670 | In stock |
Sotuletinib hydrochloride 相关产品
产品描述 | Sotuletinib hydrochloride (BLZ945 HCl) is a selective, brain-penetrant CSF-1R (c-Fms) inhibitor (IC50=1 nM), exhibiting 1000-fold greater selectivity than other receptor tyrosine kinase homologues. It elevates liver enzymes and induces Kupffer cell depletion, making it suitable for studying amyotrophic lateral sclerosis (ALS) and metastatic triple-negative breast cancer (TNBC). |
靶点活性 | CSF1R (FMS):1 nM |
体外活性 | 方法:使用Sotuletinib hydrochloride(67nM-6700nM)处理骨髓来源的巨噬细胞(BMDMs),通过MTT实验评估细胞增殖情况。 |
体内活性 | 方法:Sotuletinib hydrochloride(200 mg/kg,每天一次)对MMTV-PyMT小鼠进行口服灌胃给药,评估Sotuletinib hydrochloride对肿瘤生长、TAMs和CD8+ T细胞的影响。 |
别名 | 索妥替尼盐酸盐 |
分子量 | 434.94 |
分子式 | C20H23ClN4O3S |
CAS No. | 2222138-31-8 |
Smiles | N(C=1SC=2C(N1)=CC=C(OC=3C=C(C(NC)=O)N=CC3)C2)[C@H]4[C@H](O)CCCC4.Cl |
颜色 | White |
物理性状 | Solid |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80.00 mg/mL (183.93 mM), Sonication is recommended. H2O: 80.00 mg/mL (183.93 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
|
评论内容